7 questions about the Trump and Ukraine impeachment hearings, answered
PolitiFact readers asked us several questions related to the impeachment inquiry and public House hearings.
PolitiFact readers asked us several questions related to the impeachment inquiry and public House hearings.
The House’s impeachment inquiry moved to a new phase on Dec. 4, as the House Judiciary Committee invited four legal scholars -- three called by Democrats, one by Republicans -- to testify about the history and law of impeachment.
PolitiFact has previously reported on the similarities and differences between Ukrainian and Russian election meddling. But we decided to take a closer look at the Politico story to outline what it does — and doesn’t — show about Ukraine’s involvement in 2016.
After deciding not to run, the former Massachusetts jumped into the Democratic primary as a centrist candidate. Here's his profile.
President Donald Trump repeated several falsehoods about Ukraine, Russia and the impeachment inquiry during an interview on Fox & Friends.
Lt. Col. Alexander Vindman managed Ukraine policy for the White House National Security Council. What he saw doesn't line up with the Republican version of events.
Former ambassador to Ukraine Marie Yovanovitch might have been the only witness in Friday’s impeachment hearing, but she was upstaged by a tweet from President Donald Trump.
Yovanovich ended up crosswise with Trump and Giuliani. She told the impeachment inquiry committees how it unfolded for her.
The Democrats called on American diplomats in Ukraine to offer public testimony about the Trump administration's pressure on Ukraine to investigate Burisma and the Bidens. The Republicans called it another attempt to undermine the 2016 election.
Warren's plan to fund Medicare for All costs trillions and spans a decade. Precision is hard to achieve.
Odds of space debris falling and hitting someone on Earth? Trillion to 1. But the threat to other satellites is real.
Medicare for All would replace private insurance with public insurance. Its backers promise better coverage at a much lower cost for the great majority of people, but there are many skeptics.